MedTrace Logo

Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

NCT02934555 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2021-02-15

Study results available
· View outcomes & findings →

Summary

To study the effects of ubiquinol as a "metabolic resuscitator" in post-cardiac arrest.

Conditions

  • Cardiac Arrest

Interventions

DRUG

Ubiquinol

300 mg Ubiquinol (3 mL liquid Ubiquinol).

DIETARY_SUPPLEMENT

Ensure

50 mL Ensure

Sponsors & Collaborators

Principal Investigators

  • Michael W Donnino, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-05-25
Completion
2019-06-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02934555 on ClinicalTrials.gov